Biotechnology Stocks I Performance Guide: Summit Therapeutics Inc. (SMMT)
SMMT has no dividends
Table and Chart of SMMT Performance
See what a $1,000 investment in SMMT is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| SMMT Returns | |
|---|---|
| Start Date | Apr-30-2015 |
| Start Price | $10.44 |
| End Date | Dec-01-2023 |
| End Price | $2.13 |
| # Prices | 105 |
| Min Date | Nov-30-2022 |
| Min Price | $0.80 |
| Max Date | Jul-31-2017 |
| Max Price | $13.98 |
| Total Return | -79.60% |
| Annualized Return | -16.61% |
| Current Value of $1,000 Purchase | $204 |
| Number Returns | 5,460 |
| Average Return | -15.15% |
| Number Profitable Returns | 1,634 |
| Percent Profitable Returns | 29.93% |
| Number Unprofitable Returns | 3,826 |
| Percent Unprofitable Returns | 70.07% |
| Profitable to Unprofitable Returns Ratio | 0.43 |
| SMMT Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,492,796,000 | Price to Sales | 753.90 |
| Earnings per Share | $-1.0200 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 15.02 |
| PRICE DATA | |
| 52 Week High | $5.78 |
| 52 Week Low | $1.19 |
| Analyst Target Price | $5 |
| 50-Day Moving Average | $1.887 |
| 200-Day Moving Average | $1.856 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -5.14% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
SMMT Compare Returns with S&P 500
SMMT Trendline Chart